Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin

Tsivou, M; Dimopoulou, H; Georgakopoulos, D; Koupparis, M; Atta-Politou, J; Georgakopoulos, C

dc.contributor.author	Tsivou, M	en
dc.contributor.author	Dimopoulou, H	en
dc.contributor.author	Georgakopoulos, D	en
dc.contributor.author	Koupparis, M	en
dc.contributor.author	Atta-Politou, J	en
dc.contributor.author	Georgakopoulos, C	en
dc.date.accessioned	2014-03-01T01:59:33Z
dc.date.available	2014-03-01T01:59:33Z
dc.date.issued	2010	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/28963
dc.subject	Elevated Temperature	en
dc.subject	Erythropoietin	en
dc.subject	High Temperature	en
dc.subject	Human Chorionic Gonadotropin	en
dc.subject	Protease Inhibitor	en
dc.subject	Proteolytic Enzyme	en
dc.subject	Urinary Tract Infection	en
dc.subject	World Anti Doping Agency	en
dc.title	Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin	en
heal.type	journalArticle	en
heal.identifier.primary	10.1007/s00216-010-4033-9	en
heal.identifier.secondary	http://dx.doi.org/10.1007/s00216-010-4033-9	en
heal.publicationDate	2010	en
heal.abstract	The presence of proteolytic enzymes in urine samples, coming from exogenous or endogenous sources, enhances the cleavage of human chorionic gonadotropin (hCG). Moreover, elevated temperatures occurring occasionally during the delayed transportation of sport urine samples, favor the nicking of the hCG molecule. The aim of the current study, funded by the World Anti-Doping Agency (WADA), was the application of a	en
heal.journalName	Analytical and Bioanalytical Chemistry	en
dc.identifier.doi	10.1007/s00216-010-4033-9	en